🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 17 of 78

  1. US 10780147

    Vault complexes for cytokine delivery

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10780185

    Multifunctional nanoparticle bioconjugates for photoacoustic-based recording of cellular membrane potential

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10772897

    Method for on-demand contraception

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10772924

    Therapeutic use of chardonnay seed products

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10772849

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10765694

    Compositions and methods for delivering inhibitory oligonucleotides

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10765627

    Immunogenic composition against Campylobacter jejuni

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10767184

    Chimeric antigen receptors targeting B-cell maturation antigen

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10759795

    Aza-A-ring indenoisoquinoline topoisomerase I poisons

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10759838

    Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10758614

    Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10758613

    Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10758526

    Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10744193

    Immunogenic RSV polypeptides

    Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10738047

    Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10738312

    Chimeric antigen receptors targeting B-cell maturation antigen

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10738116

    Dual specific anti-CD22-anti-CD19 chimeric antigen receptors

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10737995

    Nuclear receptor modulators and their use for the treatment and prevention of cancer

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10738313

    Chimeric antigen receptors targeting B-cell maturation antigen

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10729650

    Skin punch biopsy and wound-debridgement training model

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10729756

    Viable viruses with foreign tags

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10730941

    Antigen-binding proteins targeting CD56 and uses thereof

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10730835

    Thalidomide analogs and methods of use

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10729534

    Methods of treating a musculoskeletal tissue interface injury using decellularized composite tissue bioscaffolds

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10722459

    Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10722561

    Aquaporin 2 protects cattle from ticks and tick-borne parasites

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10724007

    Development of dengue virus vaccine components

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10723803

    CD47 targeted therapies for the treatment of infectious disease

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10723857

    Polyimide aerogels with reduced shrinkage from isothermal aging

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10723787

    Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10716809

    Methods of producing enriched populations of tumor reactive T cells from peripheral blood

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10716793

    Treprostinil administration by inhalation

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10716843

    Immune enhancing recombinant dengue protein

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10709790

    Chemical conjugates of Evans Blue derivatives and their use in the production of long-acting therapeutics

    Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10711068

    Anti-CD133 monoclonal antibodies and related compositions and methods

    Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10704076

    Multi-tiered high through-put screen for compounds effective against bacterial biofilm and compounds effective for inhibiting and eradicating bacterial biofilm

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10703816

    M971 chimeric antigen receptors

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10702525

    Pyrimidine derivatives as anti-diabetic agents

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10702543

    Intranuclear protein transduction through a nucleoside salvage pathway

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10703746

    Mutant IDH1 inhibitors useful for treating cancer

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10695355

    Methods for pharmacologic treatment of stroke

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10695414

    Modulation of replicative fitness by deoptimization of synonymous codons

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10696631

    Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10695308

    Inhalation formulations of treprostinil

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10688063

    Treating and/or preventing insulin-resistance related weight gain

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10689422

    Recombinant polypeptide construct comprising multiple enterotoxigenic Escherichia coli fimbrial subunits

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10689456

    Anti-CD70 chimeric antigen receptors

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10683316

    Synthetic catalase/superoxide dismutase mimetics and methods for treating viral infections

    Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.